Fresenius Medical Care announced the appointment of Joseph E. (Joe) Turk as a new member of its Management Board, effective January 1, 2026. Mr. Turk will serve as Chief Executive Officer of the global operating segment Care Enablement.
Mr. Turk's appointment is part of a planned transition, as he will succeed Dr. Katarzyna Mazur-Hofsäß, who informed the Supervisory Board of her intention to retire. Mr. Turk joined Fresenius Medical Care in 2019 and currently serves as Executive Vice President of Global Home and Critical Care Therapies.
Michael Sen, Chairman of the Supervisory Board, stated that Mr. Turk's expertise will be instrumental in continuing the margin improvement track of Care Enablement and successfully rolling out the innovative 5008X CAREsystem to the U.S. This internal promotion ensures continuity in the execution of the FME Reignite strategy.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.